Form 4: Guardant Health Director Exercises Stock Options
SEC Form 4 Filing
Meghan V. Joyce, a director at Guardant Health, Inc., executed stock options on February 4, 2025.
Summary
- On February 4, 2025, Meghan V. Joyce, a director of Guardant Health, Inc., executed stock options.
- This transaction involved 66 shares of common stock at a price of $0.
- Following the transaction, Joyce directly owns 7,747 shares of Guardant Health common stock.
- The transaction also involved restricted stock units, with 66 units exercised.
- The restricted stock units vest over a three-year period, starting August 4, 2022, with 25% vesting initially and the remaining 75% vesting monthly.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine filing related to stock option exercises by a director.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be an indicator of management's confidence in the company's future prospects.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a standard stock option exercise.
Key Dates
| Date | Description |
|---|---|
| August 4, 2022 | Initial vesting date for 25% of the restricted stock units. |
| February 4, 2025 | Date of transaction: stock options exercised. |
| February 5, 2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.